Original Biomedicals CoROCO:6483 32 EV-to-FCF is -7.83 as of Jul. 13, 2026. GuruFocus rates ROCO:6483 with a GF Score™ of 32/100. The stock has 2 warning signs investors should review. Among 562 Drug Manufacturers companies, Original Biomedicals Co ranks worse than 177935.77% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Original Biomedicals Co's Enterprise Value is NT$759.65 Mil.
Original Biomedicals Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-96.96 Mil. Therefore, Original Biomedicals Co's EV-to-FCF for today is -7.83.
The historical rank and industry rank for Original Biomedicals Co's EV-to-FCF or its related term are showing as below:
ROCO:6483'
s EV-to-FCF Range Over the Past 10 Years
Min: -25.14 Med: 2.15 Max: 2.15
Current: -7.83
During the past 9 years, the highest EV-to-FCF of Original Biomedicals Co was 2.15. The lowest was -25.14. And the median was 2.15.
ROCO:6483's EV-to-FCF is ranked worse than 100% of 562
companies
in the Drug Manufacturers industry
Industry Median: 20.955
vs ROCO:6483: -7.83
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Original Biomedicals Co (ROCO:6483) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Original Biomedicals Co's PE Ratio (TTM) for today is calculated as:
Original Biomedicals Co's share price for today is NT$13.40.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Original Biomedicals Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-1.530.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Original Biomedicals Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Original Biomedicals Co EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Original Biomedicals Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Original Biomedicals Co's EV-to-FCF falls into.
Original Biomedicals Co's current Enterprise Value is NT$759.65 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Original Biomedicals Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-96.96 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Original Biomedicals Co (ROCO:6483) has a EV-to-FCF of -7.83 as of Jul. 13, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Original Biomedicals Co and its competitors. According to the industry distribution chart, Original Biomedicals Co ranks #999999 out of 562 companies in the Drug Manufacturers industry.
Is Original Biomedicals Co's EV-to-FCF too high?
Original Biomedicals Co's current EV-to-FCF is -7.83. Based on the distribution chart, Original Biomedicals Co ranks #999999 out of 562 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Original Biomedicals Co has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Original Biomedicals Co's EV-to-FCF compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Original Biomedicals Co ranks #999999 out of 562 companies for EV-to-FCF. This places Original Biomedicals Co in the lower half of its industry. The industry median EV-to-FCF is 20.96. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 20.96, based on 562 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Original Biomedicals Co and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 20.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Original Biomedicals Co's current EV-to-FCF is -7.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Original Biomedicals Co stock overvalued right now?
Original Biomedicals Co (ROCO:6483) has a current EV-to-FCF of -7.83. The current EV-to-FCF is -7.83. Original Biomedicals Co's overall GF Score™ is 32/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Original Biomedicals Co (ROCO:6483), the current EV-to-FCF is -7.83 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Original Biomedicals Co Ltd is a biopharmaceutical company engaged in the research and development of drugs. The company focuses on developing new drug formulations, drug delivery systems, and repurposing existing pharmaceutical products.
32GF Score
Get the complete analysis for ROCO:6483
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6483 has been successfully added to your 
